Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
PERICLES
Abandoned - No Statement Of Use F…
Show more
Class 5: pharmaceutical preparations for human use, namely, pharmaceutical preparations for the treatment and prevention of metabolic, musculoskeletal, cardiovascular, cardiopulmonary, respiratory, neuromuscular, central nervous system, neurological and genetic diseases and disorders and for the regulation of protein production; cell and gene therapy products for human use in the nature of therapeutic pharmaceuticals containing viral vectors for the treatment and prevention of metabolic, musculoskeletal, cardiovascular, cardiopulmonary, respiratory, neuromuscular, central nervous system, neurological and genetic diseases and disorders and for the regulation of protein production
Class 44: providing health information
Class 5 – Pharmaceuticals & supplementsClass 44 – Medical & beauty services
Status timeline
- 18 May 2024Application filedNew Application Entered
- 3 Dec 2024Assigned to an examining attorneyAssigned To Examiner
- 17 Dec 2024Office action issuedNon-Final Action Written
- 7 Apr 2025Assigned to an examining attorneyAssigned To Examiner
- 13 Jun 2025Response to office action filedTeas Response To Office Action Received
- 16 Jun 2025Approved for publicationApproved For Pub - Principal Register
- 22 Jul 2025Published for oppositionPublished For Opposition
- 16 Sep 2025Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 20 Apr 2026Application abandoned — no statement of use filedAbandonment - No Use Statement Filed
All 19 events
| 2026-04-20 | Abandonment - No Use Statement Filed |
| 2026-04-20 | Abandonment Notice Mailed - No Use Statement Filed |
| 2025-09-16 | Noa Mailed - Sou Required From Applicant |
| 2025-07-22 | Published For Opposition |
| 2025-07-22 | Official Gazette Publication Confirmation E-Mailed |
| 2025-07-16 | Notification Of Notice Of Publication E-Mailed |
| 2025-06-16 | Approved For Pub - Principal Register |
| 2025-06-13 | Teas Response To Office Action Received |
| 2025-06-13 | Correspondence Received In Law Office |
| 2025-06-13 | Teas/Email Correspondence Entered |
| 2025-04-07 | Assigned To Examiner |
| 2025-03-12 | Application Extension To Response Period - Received |
| 2025-03-12 | Application Extension Granted/Receipt Provided |
| 2024-12-17 | Non-Final Action Written |
| 2024-12-17 | Non-Final Action E-Mailed |
| 2024-12-17 | Notification Of Non-Final Action E-Mailed |
| 2024-12-03 | Assigned To Examiner |
| 2024-11-21 | New Application Office Supplied Data Entered |
| 2024-05-18 | New Application Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
pharmaceutical preparations for human use, namely, pharmaceutical preparations for the treatment and prevention of metabolic, musculoskeletal, cardiovascular, cardiopulmonary, respiratory, neuromuscular, central nervous system, neurological and genetic diseases and disorders and for the regulation of protein production; cell and gene therapy products for human use in the nature of therapeutic pharmaceuticals containing viral vectors for the treatment and prevention of metabolic, musculoskeletal, cardiovascular, cardiopulmonary, respiratory, neuromuscular, central nervous system, neurological and genetic diseases and disorders and for the regulation of protein production
Class 44 Medical & beauty services
providing health information
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 21 Apr 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.